ATE393630T1 - Verfahren zur prevention von gastritis unter verwendung von amylin oder amylin agonisten - Google Patents

Verfahren zur prevention von gastritis unter verwendung von amylin oder amylin agonisten

Info

Publication number: ATE393630T1
Authority: AT; Austria
Prior art keywords: amylin; gastritis; agonist; prevention; agonists
Prior art date: 1997-05-06

Application number

AT98920218T

Other languages

English (en)

Inventor

Andrew Young

Bronislava Gedulin

Gareth Beynon

Original Assignee

Amylin Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-06

Filing date

1998-05-06

Publication date

2008-05-15

1998-05-06 Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc

2008-05-15 Application granted granted Critical

2008-05-15 Publication of ATE393630T1 publication Critical patent/ATE393630T1/de

Links

102000036770 Islet Amyloid Polypeptide Human genes 0.000 title abstract 10
108010041872 Islet Amyloid Polypeptide Proteins 0.000 title abstract 10
208000007882 Gastritis Diseases 0.000 title abstract 2
229940127438 Amylin Agonists Drugs 0.000 title 1
230000002265 prevention Effects 0.000 title 1
239000000556 agonist Substances 0.000 abstract 5
238000009472 formulation Methods 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
102000055006 Calcitonin Human genes 0.000 abstract 1
108060001064 Calcitonin Proteins 0.000 abstract 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
229960004015 calcitonin Drugs 0.000 abstract 1
238000007911 parenteral administration Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Endocrinology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Toxicology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT98920218T 1997-05-06 1998-05-06 Verfahren zur prevention von gastritis unter verwendung von amylin oder amylin agonisten ATE393630T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/851,965 US7101853B2 (en)	1997-05-06	1997-05-06	Method for treating or preventing gastritis using amylin or amylin agonists

Publications (1)

Publication Number	Publication Date
ATE393630T1 true ATE393630T1 (de)	2008-05-15

Family

ID=25312164

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98920218T ATE393630T1 (de)	1997-05-06	1998-05-06	Verfahren zur prevention von gastritis unter verwendung von amylin oder amylin agonisten

Country Status (9)

Country	Link
US (1)	US7101853B2 (de)
EP (2)	EP0981360B1 (de)
JP (1)	JP2001526656A (de)
AT (1)	ATE393630T1 (de)
AU (1)	AU7284098A (de)
CA (1)	CA2289548A1 (de)
DE (1)	DE69839423T2 (de)
ES (1)	ES2302353T3 (de)
WO (1)	WO1998050059A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69739172D1 (de)	1996-08-08	2009-01-29	Amylin Pharmaceuticals Inc	Regulation gastrointestinaler beweglichkeit
DE602005021858D1 (de)	2004-02-11	2010-07-29	Amylin Pharmaceuticals Inc	Peptide der amylin familie, verfahren zu deren herstellung und verwendung
US7399744B2 (en)	2004-03-04	2008-07-15	Amylin Pharmaceuticals, Inc.	Methods for affecting body composition
US7759312B2 (en) *	2005-03-11	2010-07-20	Endo Pharmaceuticals Solutions Inc.	Delivery of dry formulations of octreotide
NZ561400A (en) *	2005-03-11	2010-02-26	Endo Pharmaceuticals Solutions	Controlled release formulations of octreotide
US7671023B2 (en)	2005-03-31	2010-03-02	Amylin Pharmaceuticals, Inc.	Amylin agonist for treating depression, anxiety disorder and schizophrenia
US8168592B2 (en) *	2005-10-21	2012-05-01	Amgen Inc.	CGRP peptide antagonists and conjugates
US11225404B2 (en)	2006-12-13	2022-01-18	Crown Equipment Corporation	Information system for industrial vehicles
WO2009158412A2 (en)	2008-06-25	2009-12-30	Endo Pharmaceuticals Solutions Inc.	Sustained delivery of exenatide and other polypeptides
UA104866C2 (uk) *	2008-06-25	2014-03-25	Ендо Фармас'Ютікалз Солюшнз Інк.	Імплантат октреотиду, який містить вивільняючу речовину
BR102013017626A2 (pt) *	2013-06-14	2015-02-10	Univ Rio De Janeiro	Bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, uso de bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, composições farmacêuticas de baixa toxicidade, adjuvante para a prevenção ou tratamento das doenças, medicamento, método de tratamento ou prevenção de doenças.
JP2015066978A (ja) *	2013-09-26	2015-04-13	ヤマハ発動機株式会社	船舶用表示システムおよびそれを備えた小型船舶
EA035791B1 (ru)	2015-03-18	2020-08-11	Зилэнд Фарма А/С	Аналоги амилина
AR109514A1 (es)	2016-09-09	2018-12-19	Zealand Pharma As	Análogos de amilina
HUE066356T2 (hu)	2017-08-24	2024-07-28	Novo Nordisk As	GLP-1 készítmények és alkalmazásaik
US11274158B2 (en) *	2018-01-30	2022-03-15	Flagship Pioneering Innovations V, Inc.	Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators
CA3097812A1 (en) *	2018-04-25	2019-10-31	Janssen Pharmaceutica Nv	Thioether cyclic peptide amylin receptor modulators
PE20221575A1 (es)	2020-02-18	2022-10-06	Novo Nordisk As	Formulaciones farmaceuticas
MX2024005969A (es)	2022-05-30	2024-06-11	Zealand Pharma As	Formulaciones liquidas de analogos de amilina.

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3514097A (en)	1967-11-13	1970-05-26	Gen Binding Corp Canada Ltd	Folding apparatus for paper and the like
US4528193A (en) *	1978-12-27	1985-07-09	A. Natterman & Cie. Gmbh	Inflammation-preventing pharmaceutical composition of oral administration
US4530838A (en) *	1983-07-08	1985-07-23	The Salk Institute For Biological Studies	Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals
US5367052A (en)	1987-04-27	1994-11-22	Amylin Pharmaceuticals, Inc.	Amylin peptides
GB8720115D0 (en)	1987-08-26	1987-09-30	Cooper G J S	Treatment of diabetes mellitus
US5175145A (en)	1988-08-26	1992-12-29	Amylin Pharmaceuticals, Inc.	Treatment of diabetes mellitus with amylin agonists
US5321008A (en) *	1991-01-10	1994-06-14	Amylin Pharmaceuticals, Inc.	Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
US5264372A (en)	1991-03-15	1993-11-23	Amylin Pharmaceuticals, Inc.	Receptor-based screening methods for amylin agonists and antagonists
US5234906A (en)	1991-01-10	1993-08-10	Amylin Pharmaceuticals, Inc.	Hyperglycemic compositions
HU222249B1 (hu)	1991-03-08	2003-05-28	Amylin Pharmaceuticals Inc.	Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
MD960317A (ro) *	1991-11-19	1998-05-31	Anylin Pharmaceuticals, Inc.	Noile peptide-agoniste ale amilinei şi utilizarea lor
US5376638A (en)	1992-09-01	1994-12-27	Amylin Pharmaceuticals, Inc.	Methods for treating renin-related disorders with amylin antagonists
CN1095284A (zh) *	1993-05-15	1994-11-23	浙江永宁制药厂	治疗胃与十二指肠溃疡的药物配方和加工方法
BR9407424A (pt)	1993-09-07	1996-04-09	Amylin Pharmaceuticals Inc	Métodos para regular motilidade gastrointestinal
US6143718A (en) *	1995-06-07	2000-11-07	Amylin Pharmaceuticals, Inc.	Treatment of Type II diabetes mellutis with amylin agonists
CN1055219C (zh) *	1995-07-21	2000-08-09	哈尔滨世一堂制药厂	一种治疗胃病的药物及其制法
US5677279A (en)	1996-12-16	1997-10-14	Amylin Pharmaceuticals, Inc.	Methods and compositions for treating pain with amylin or agonists thereof
US6410511B2 (en)	1997-01-08	2002-06-25	Amylin Pharmaceuticals, Inc.	Formulations for amylin agonist peptides
US11838193B1 (en)	2022-12-16	2023-12-05	Amazon Technologies, Inc.	Real-time load limit measurement for a plurality of nodes

1997
- 1997-05-06 US US08/851,965 patent/US7101853B2/en not_active Expired - Fee Related
1998
- 1998-05-06 ES ES98920218T patent/ES2302353T3/es not_active Expired - Lifetime
- 1998-05-06 CA CA002289548A patent/CA2289548A1/en not_active Abandoned
- 1998-05-06 JP JP54835298A patent/JP2001526656A/ja active Pending
- 1998-05-06 EP EP98920218A patent/EP0981360B1/de not_active Expired - Lifetime
- 1998-05-06 DE DE69839423T patent/DE69839423T2/de not_active Expired - Lifetime
- 1998-05-06 EP EP07023563A patent/EP1952819A3/de not_active Withdrawn
- 1998-05-06 AU AU72840/98A patent/AU7284098A/en not_active Abandoned
- 1998-05-06 WO PCT/US1998/009089 patent/WO1998050059A1/en not_active Ceased
- 1998-05-06 AT AT98920218T patent/ATE393630T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1952819A3 (de)	2008-10-22
JP2001526656A (ja)	2001-12-18
CA2289548A1 (en)	1998-11-12
DE69839423T2 (de)	2009-06-04
US7101853B2 (en)	2006-09-05
EP1952819A2 (de)	2008-08-06
ES2302353T3 (es)	2008-07-01
EP0981360B1 (de)	2008-04-30
AU7284098A (en)	1998-11-27
WO1998050059A1 (en)	1998-11-12
DE69839423D1 (de)	2008-06-12
EP0981360A4 (de)	2001-05-23
US20020010133A1 (en)	2002-01-24
EP0981360A1 (de)	2000-03-01

Similar Documents

Publication	Publication Date	Title
DE69839423D1 (de)	2008-06-12	Verfahren zur prevention von gastritis unter verwendung von amylin oder amylin agonisten
YU39695A (sh)	1997-08-22	Formulacija analoga insulina
ES2162615T3 (es)	2002-01-01	Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
DE3583008D1 (de)	1991-07-04	Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren.
ATE322905T1 (de)	2006-04-15	Verfahren zur hemmung der fibrose mittels eines somatostatin-agonisten
ATE96678T1 (de)	1993-11-15	Verfahren zur verminderung von hautirritationen bei anwendung von durchdringungsverstaerkenden arzneimittelzusammensetzungen.
BR9910180A (pt)	2001-01-09	Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
NO920051D0 (no)	1992-01-03	Farmasoeytisk sammensetning for slanking
DE69533112T2 (de)	2004-10-21	Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken
DE69230112D1 (de)	1999-11-11	Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
PT772451E (pt)	2003-04-30	Tratamento da diabetes mellitus tipo ii com antagonistas de amilina
ATE125706T1 (de)	1995-08-15	Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis.
DE69805983D1 (de)	2002-07-18	Hustenhemmende, theobromine enthaltende zusammensetzungen
EE04953B1 (et)	2008-02-15	Tsinkhaluronaadi kasutamine ja meetod ravimkoostise valmistamiseks
FR2585572B3 (fr)	1987-12-31	Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse
BR9915390A (pt)	2001-08-07	Tratamento de tumores através de administração de compostos que liberam harmÈnio de crescimento e seus antagonistas
KR910000794A (ko)	1991-01-30	Vip-유사체 ⅱ
PT980253E (pt)	2004-08-31	Somatostatina e agonistas de somatostatina para tratar a insensibilidade a insulina e a sindrome x
ATE200617T1 (de)	2001-05-15	Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge
IL126175A0 (en)	1999-05-09	Method or treating heart failure with endothelin antagonists and pharmaceutical compositions containing the same
EP0799618A3 (de)	1997-11-12	Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
ATE245998T1 (de)	2003-08-15	Somatostatin agoniste zur reduzierung von körpergewicht
ATE372785T1 (de)	2007-09-15	Verfahren zur verabreichung von arzneimitteln mit bindungsaffinität zum plasmaprotein und verwendung der zusammensetzung in dem verfahren
KR880004810A (ko)	1988-06-27	소화성 궤양 치료제
PL328924A1 (en)	1999-03-01	Method of treating abuse of substances

Legal Events

Date	Code	Title	Description
2008-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties